(R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria

Jeffrey S. Monette, Luis A. Gómez, Régis F. Moreau, Kevin C. Dunn, Judy A. Butler, Liam A. Finlay, Alexander J. Michels, Kate Petersen Shay, Eric J. Smith, Tory M. Hagen

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Inflammation results in heightened mitochondrial ceramide levels, which cause electron transport chain dysfunction, elevates reactive oxygen species, and increases apoptosis. As mitochondria in aged hearts also display many of these characteristics, we hypothesized that mitochondrial decay stems partly from an age-related ceramidosis that heretofore has not been recognized for the heart. Intact mitochondria or their purified inner membranes (IMM) were isolated from young (4-6 mo) and old (26-28 mo) rats and analyzed for ceramides by LC-MS/MS. Results showed that ceramide levels increased by 32% with age and three ceramide isoforms, found primarily in the IMM (e.g. C16-, C18-, and C24:1-ceramide), caused this increase. The ceramidosis may stem from enhanced hydrolysis of sphingomyelin, as neutral sphingomyelinase (nSMase) activity doubled with age but with no attendant change in ceramidase activity. Because (R)-α-lipoic acid (LA) improves many parameters of cardiac mitochondrial decay in aging and lowers ceramide levels in vascular endothelial cells, we hypothesized that LA may limit cardiac ceramidosis and thereby improve mitochondrial function. Feeding LA [0.2%, w/w] to old rats for two weeks prior to mitochondrial isolation reversed the age-associated decline in glutathione levels and concomitantly improved Complex IV activity. This improvement was associated with lower nSMase activity and a remediation in mitochondrial ceramide levels. In summary, LA treatment lowers ceramide levels to that seen in young rat heart mitochondria and restores Complex IV activity which otherwise declines with age.

Original languageEnglish (US)
Pages (from-to)23-29
Number of pages7
JournalPharmacological Research
Volume63
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Thioctic Acid
Ceramides
Mitochondria
Sphingomyelin Phosphodiesterase
Ceramidases
Heart Mitochondria
Membranes
Sphingomyelins
Electron Transport
Glutathione
Reactive Oxygen Species
Protein Isoforms
Hydrolysis
Endothelial Cells
Apoptosis
Inflammation

Keywords

  • Complex IV
  • Electron transport
  • LC-mass spectrometry
  • Sphingomyelinase

ASJC Scopus subject areas

  • Pharmacology

Cite this

Monette, J. S., Gómez, L. A., Moreau, R. F., Dunn, K. C., Butler, J. A., Finlay, L. A., ... Hagen, T. M. (2011). (R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria. Pharmacological Research, 63(1), 23-29. https://doi.org/10.1016/j.phrs.2010.09.007

(R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria. / Monette, Jeffrey S.; Gómez, Luis A.; Moreau, Régis F.; Dunn, Kevin C.; Butler, Judy A.; Finlay, Liam A.; Michels, Alexander J.; Shay, Kate Petersen; Smith, Eric J.; Hagen, Tory M.

In: Pharmacological Research, Vol. 63, No. 1, 01.01.2011, p. 23-29.

Research output: Contribution to journalArticle

Monette, JS, Gómez, LA, Moreau, RF, Dunn, KC, Butler, JA, Finlay, LA, Michels, AJ, Shay, KP, Smith, EJ & Hagen, TM 2011, '(R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria', Pharmacological Research, vol. 63, no. 1, pp. 23-29. https://doi.org/10.1016/j.phrs.2010.09.007
Monette, Jeffrey S. ; Gómez, Luis A. ; Moreau, Régis F. ; Dunn, Kevin C. ; Butler, Judy A. ; Finlay, Liam A. ; Michels, Alexander J. ; Shay, Kate Petersen ; Smith, Eric J. ; Hagen, Tory M. / (R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria. In: Pharmacological Research. 2011 ; Vol. 63, No. 1. pp. 23-29.
@article{c6eb133e0ada4132958d1ef08a2d5d1b,
title = "(R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria",
abstract = "Inflammation results in heightened mitochondrial ceramide levels, which cause electron transport chain dysfunction, elevates reactive oxygen species, and increases apoptosis. As mitochondria in aged hearts also display many of these characteristics, we hypothesized that mitochondrial decay stems partly from an age-related ceramidosis that heretofore has not been recognized for the heart. Intact mitochondria or their purified inner membranes (IMM) were isolated from young (4-6 mo) and old (26-28 mo) rats and analyzed for ceramides by LC-MS/MS. Results showed that ceramide levels increased by 32{\%} with age and three ceramide isoforms, found primarily in the IMM (e.g. C16-, C18-, and C24:1-ceramide), caused this increase. The ceramidosis may stem from enhanced hydrolysis of sphingomyelin, as neutral sphingomyelinase (nSMase) activity doubled with age but with no attendant change in ceramidase activity. Because (R)-α-lipoic acid (LA) improves many parameters of cardiac mitochondrial decay in aging and lowers ceramide levels in vascular endothelial cells, we hypothesized that LA may limit cardiac ceramidosis and thereby improve mitochondrial function. Feeding LA [0.2{\%}, w/w] to old rats for two weeks prior to mitochondrial isolation reversed the age-associated decline in glutathione levels and concomitantly improved Complex IV activity. This improvement was associated with lower nSMase activity and a remediation in mitochondrial ceramide levels. In summary, LA treatment lowers ceramide levels to that seen in young rat heart mitochondria and restores Complex IV activity which otherwise declines with age.",
keywords = "Complex IV, Electron transport, LC-mass spectrometry, Sphingomyelinase",
author = "Monette, {Jeffrey S.} and G{\'o}mez, {Luis A.} and Moreau, {R{\'e}gis F.} and Dunn, {Kevin C.} and Butler, {Judy A.} and Finlay, {Liam A.} and Michels, {Alexander J.} and Shay, {Kate Petersen} and Smith, {Eric J.} and Hagen, {Tory M.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.phrs.2010.09.007",
language = "English (US)",
volume = "63",
pages = "23--29",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - (R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria

AU - Monette, Jeffrey S.

AU - Gómez, Luis A.

AU - Moreau, Régis F.

AU - Dunn, Kevin C.

AU - Butler, Judy A.

AU - Finlay, Liam A.

AU - Michels, Alexander J.

AU - Shay, Kate Petersen

AU - Smith, Eric J.

AU - Hagen, Tory M.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Inflammation results in heightened mitochondrial ceramide levels, which cause electron transport chain dysfunction, elevates reactive oxygen species, and increases apoptosis. As mitochondria in aged hearts also display many of these characteristics, we hypothesized that mitochondrial decay stems partly from an age-related ceramidosis that heretofore has not been recognized for the heart. Intact mitochondria or their purified inner membranes (IMM) were isolated from young (4-6 mo) and old (26-28 mo) rats and analyzed for ceramides by LC-MS/MS. Results showed that ceramide levels increased by 32% with age and three ceramide isoforms, found primarily in the IMM (e.g. C16-, C18-, and C24:1-ceramide), caused this increase. The ceramidosis may stem from enhanced hydrolysis of sphingomyelin, as neutral sphingomyelinase (nSMase) activity doubled with age but with no attendant change in ceramidase activity. Because (R)-α-lipoic acid (LA) improves many parameters of cardiac mitochondrial decay in aging and lowers ceramide levels in vascular endothelial cells, we hypothesized that LA may limit cardiac ceramidosis and thereby improve mitochondrial function. Feeding LA [0.2%, w/w] to old rats for two weeks prior to mitochondrial isolation reversed the age-associated decline in glutathione levels and concomitantly improved Complex IV activity. This improvement was associated with lower nSMase activity and a remediation in mitochondrial ceramide levels. In summary, LA treatment lowers ceramide levels to that seen in young rat heart mitochondria and restores Complex IV activity which otherwise declines with age.

AB - Inflammation results in heightened mitochondrial ceramide levels, which cause electron transport chain dysfunction, elevates reactive oxygen species, and increases apoptosis. As mitochondria in aged hearts also display many of these characteristics, we hypothesized that mitochondrial decay stems partly from an age-related ceramidosis that heretofore has not been recognized for the heart. Intact mitochondria or their purified inner membranes (IMM) were isolated from young (4-6 mo) and old (26-28 mo) rats and analyzed for ceramides by LC-MS/MS. Results showed that ceramide levels increased by 32% with age and three ceramide isoforms, found primarily in the IMM (e.g. C16-, C18-, and C24:1-ceramide), caused this increase. The ceramidosis may stem from enhanced hydrolysis of sphingomyelin, as neutral sphingomyelinase (nSMase) activity doubled with age but with no attendant change in ceramidase activity. Because (R)-α-lipoic acid (LA) improves many parameters of cardiac mitochondrial decay in aging and lowers ceramide levels in vascular endothelial cells, we hypothesized that LA may limit cardiac ceramidosis and thereby improve mitochondrial function. Feeding LA [0.2%, w/w] to old rats for two weeks prior to mitochondrial isolation reversed the age-associated decline in glutathione levels and concomitantly improved Complex IV activity. This improvement was associated with lower nSMase activity and a remediation in mitochondrial ceramide levels. In summary, LA treatment lowers ceramide levels to that seen in young rat heart mitochondria and restores Complex IV activity which otherwise declines with age.

KW - Complex IV

KW - Electron transport

KW - LC-mass spectrometry

KW - Sphingomyelinase

UR - http://www.scopus.com/inward/record.url?scp=79151474880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79151474880&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2010.09.007

DO - 10.1016/j.phrs.2010.09.007

M3 - Article

C2 - 20934512

AN - SCOPUS:79151474880

VL - 63

SP - 23

EP - 29

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 1

ER -